Detalles de la búsqueda
1.
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
N Engl J Med
; 2024 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38767614
2.
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
N Engl J Med
; 389(3): 205-214, 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37272521
3.
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol
; 90(6): 1190-1199, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296199
4.
Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis.
J Eur Acad Dermatol Venereol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785405
5.
A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis.
Pediatr Dermatol
; 41(2): 204-209, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308453
6.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study.
Allergol Int
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735810
7.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 400(10356): 908-919, 2022 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116481
8.
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Pharm Res
; 40(11): 2653-2666, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38082089
9.
An audit of Complicated Choledochal Cysts- 15-years' experience at a tertiary care center.
Langenbecks Arch Surg
; 408(1): 212, 2023 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247085
10.
Correlation of Fetal Anterior Abdominal Wall Thickness and Other Standard Biometric Ultrasound Measurements to Predict Fetal Macrosomia in Gestational Diabetes.
J Med Ultrasound
; 31(1): 29-34, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180617
11.
The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study.
J Pediatr
; 246: 220-226.e5, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35490745
12.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083774
13.
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS.
J Am Acad Dermatol
; 82(6): 1328-1336, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135208
14.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol
; 83(5): 1282-1293, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574587
15.
Development and validation of a caregiver-reported Numeric Rating Scale for measuring worst scratch/itch in patients aged 6 months to younger than 6 years with atopic dermatitis.
J Am Acad Dermatol
; 90(2): 382-385, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778662
16.
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use.
Acta Derm Venereol
; 101(7): adv00504, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043020
17.
Dupilumab Treatment in Pediatric Patients Aged 6-11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review.
Drug Des Devel Ther
; 18: 277-289, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333897
18.
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Adv Ther
; 41(3): 1046-1061, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194047
19.
Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials.
JAMA Dermatol
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865146
20.
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.
Am J Clin Dermatol
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743155